# Gilead Sciences

Type: Company

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/gilead-sciences
Canonical HTML page: https://gethealthbrief.com/entity/gilead-sciences

## Timeline

- **2026-08-13**: NPR report details mixed rollout reviews in Uganda — A syndicated story from Kalisizo, Uganda highlights participant Irene's experience, the drug's six-month protection, and ongoing implementation challenges.
- **2026-03-15**: Expected Executive Action — The bill moves to the Governor's desk for final signing and fund disbursement.
- **2026-03-12**: Legislative Approval — The Florida Legislature approves a stopgap funding bill with bipartisan support.
- **2026-02-15**: Waitlist Warnings — Public health advocacy groups warn that thousands could lose access to medication without intervention.
- **2026-01-10**: Budget Shortfall Identified — Projections indicate a significant deficit in the ADAP budget for the current fiscal year.
- **2024**: PURPOSE 1 and PURPOSE 2 deliver unprecedented efficacy — An independent monitoring committee concluded lenacapavir was so effective that the randomized phase of both trials was halted early.

## Recent coverage (3 stories)

### Lenacapavir's 6-Month HIV PrEP Shows Promise, Rollout Gets Mixed Reviews
2026-08-13 15:39:34 · Sentiment: Neutral · Impact: 7/10 · Sources: 3

A twice-yearly injectable PrEP, lenacapavir showed unprecedented efficacy in the PURPOSE 1 and 2 trials, yet its rollout in Uganda is drawing mixed reviews. For health systems, the drug's adherence-friendly profile must clear delivery, access, and stigma barriers to achieve population-level impact.
Full story: https://gethealthbrief.com/story/lenacapavir-six-month-hiv-prep-rollout-mixed-reviews-health

### State Budget Crises Force New Restrictions on HIV Drug Assistance Programs
2026-03-17 21:17:23 · Sentiment: Negative · Impact: 6/10 · Sources: 2

Multiple states are implementing restrictive eligibility criteria and waitlists for AIDS Drug Assistance Programs (ADAPs) as rising medication costs outpace funding. These measures threaten to disrupt treatment for thousands of low-income individuals, potentially reversing years of progress in HIV viral suppression.
Full story: https://gethealthbrief.com/story/states-limit-hiv-drug-assistance-programs-adap

### Florida Legislature Restores Critical Funding to AIDS Drug Assistance Program
2026-03-13 01:37:01 · Sentiment: Positive · Impact: 6/10 · Sources: 2

The Florida Legislature has passed a stopgap measure to restore essential funding to the state's AIDS Drug Assistance Program (ADAP), averting a potential crisis for thousands of low-income residents. The move addresses a significant budget shortfall that threatened to create waitlists for life-saving antiretroviral medications.
Full story: https://gethealthbrief.com/story/florida-restores-adap-funding-2026

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.